Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece
Progression-free (a) and overall survival (b) of patients receiving first-line chemotherapy according to the chemotherapy regimen. CAPOXIRI, oxaliplatin/irinotecan/capecitabine; FOLFIRINOX, oxaliplatin/irinotecan/leucovorin/5-fluorouracil.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.